LAMEA Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)
The LAMEA Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 34.2% during 2016 -2022.
The increased and ongoing efforts of ‘patient-education’ and ‘screening for diabetes’ programs would increase the awareness levels and eventually would drive the overall diabetes treatment and management market growth. Significantly growing purchasing power among the end-user/patient base in the developing and underdeveloped regions would act as a major factor driving the market during the forecast period.
The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years. Bionic pancreas is another notable product which is a smart and a complete diabetes management solution which is majorly used for Type I diabetes patients, is another notable breakthrough within the CGMS market.
The report highlights the adoption of Continuous Glucose Monitoring Systems in LAMEA. Based on the Component, the LAMEA Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
The increased and ongoing efforts of ‘patient-education’ and ‘screening for diabetes’ programs would increase the awareness levels and eventually would drive the overall diabetes treatment and management market growth. Significantly growing purchasing power among the end-user/patient base in the developing and underdeveloped regions would act as a major factor driving the market during the forecast period.
The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years. Bionic pancreas is another notable product which is a smart and a complete diabetes management solution which is majorly used for Type I diabetes patients, is another notable breakthrough within the CGMS market.
The report highlights the adoption of Continuous Glucose Monitoring Systems in LAMEA. Based on the Component, the LAMEA Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA.
Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Continuous Glucose Monitoring Systems Market, by Component
1.4.2 LAMEA Continuous Glucose Monitoring Systems Market, by End User
1.4.3 LAMEA Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 LAMEA Continuous Glucose Monitoring Systems Market - By Component
2.4 LAMEA Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 LAMEA Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 LAMEA Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 LAMEA Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1 LAMEA Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.2 LAMEA ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 LAMEA Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 Brazil Continuous Glucose Monitoring Systems Market
5.1.1 Brazil Continuous Glucose Monitoring Systems Market - By Component
5.1.2 Brazil Continuous Glucose Monitoring Systems Market - By End User
5.2 Argentina Continuous Glucose Monitoring Systems Market
5.2.1 Argentina Continuous Glucose Monitoring Systems Market - By Component
5.2.2 Argentina Continuous Glucose Monitoring Systems Market - By End User
5.3 UAE Continuous Glucose Monitoring Systems Market
5.3.1 UAE Continuous Glucose Monitoring Systems Market - By Component
5.3.2 UAE Continuous Glucose Monitoring Systems Market - By End User
5.4 Saudi Arabia Continuous Glucose Monitoring Systems Market
5.4.1 Saudi Arabia Continuous Glucose Monitoring Systems Market - By Component
5.4.2 Saudi Arabia Continuous Glucose Monitoring Systems Market - By End User
5.5 South Africa Continuous Glucose Monitoring Systems Market
5.5.1 South Africa Continuous Glucose Monitoring Systems Market - By Component
5.5.2 South Africa Continuous Glucose Monitoring Systems Market - By End User
5.6 Nigeria Continuous Glucose Monitoring Systems Market
5.6.1 Nigeria Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Nigeria Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of LAMEA Continuous Glucose Monitoring Systems Market
5.7.1 Rest of LAMEA Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of LAMEA Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Continuous Glucose Monitoring Systems Market, by Component
1.4.2 LAMEA Continuous Glucose Monitoring Systems Market, by End User
1.4.3 LAMEA Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 LAMEA Continuous Glucose Monitoring Systems Market - By Component
2.4 LAMEA Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 3. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT
3.1 LAMEA Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 LAMEA Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 LAMEA Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
CHAPTER 4. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER
4.1 LAMEA Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.2 LAMEA ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 LAMEA Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
CHAPTER 5. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY
5.1 Brazil Continuous Glucose Monitoring Systems Market
5.1.1 Brazil Continuous Glucose Monitoring Systems Market - By Component
5.1.2 Brazil Continuous Glucose Monitoring Systems Market - By End User
5.2 Argentina Continuous Glucose Monitoring Systems Market
5.2.1 Argentina Continuous Glucose Monitoring Systems Market - By Component
5.2.2 Argentina Continuous Glucose Monitoring Systems Market - By End User
5.3 UAE Continuous Glucose Monitoring Systems Market
5.3.1 UAE Continuous Glucose Monitoring Systems Market - By Component
5.3.2 UAE Continuous Glucose Monitoring Systems Market - By End User
5.4 Saudi Arabia Continuous Glucose Monitoring Systems Market
5.4.1 Saudi Arabia Continuous Glucose Monitoring Systems Market - By Component
5.4.2 Saudi Arabia Continuous Glucose Monitoring Systems Market - By End User
5.5 South Africa Continuous Glucose Monitoring Systems Market
5.5.1 South Africa Continuous Glucose Monitoring Systems Market - By Component
5.5.2 South Africa Continuous Glucose Monitoring Systems Market - By End User
5.6 Nigeria Continuous Glucose Monitoring Systems Market
5.6.1 Nigeria Continuous Glucose Monitoring Systems Market - By Component
5.6.2 Nigeria Continuous Glucose Monitoring Systems Market - By End User
5.7 Rest of LAMEA Continuous Glucose Monitoring Systems Market
5.7.1 Rest of LAMEA Continuous Glucose Monitoring Systems Market - By Component
5.7.2 Rest of LAMEA Continuous Glucose Monitoring Systems Market - By End User
CHAPTER 6. COMPANY PROFILE
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis
LIST OF TABLES
TABLE 1 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
TABLE 1 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 4 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 5 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 6 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 7 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 8 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 9 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 LAMEA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 14 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 15 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 16 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 17 LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 LAMEA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 LAMEA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 22 LAMEA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 23 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 26 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 27 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 28 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 29 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 30 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 31 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 32 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 33 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 34 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 35 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 36 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 37 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 38 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 39 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 40 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 41 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 42 UAE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 43 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 44 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 45 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 46 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 47 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 48 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 49 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 50 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 51 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 52 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 53 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 54 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 55 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 56 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 57 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 58 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 59 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 60 NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 61 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 62 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 63 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 64 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 65 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 66 REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 67 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 68 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 69 KEY INFORMATION - DEXCOM, INC.
TABLE 70 KEY INFORMATION - NOVO NORDISK.
TABLE 71 KEY INFORMATION - YPSOMED AG.
TABLE 72 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 73 KEY INFORMATION - MEDTRONIC PLC
TABLE 74 KEY INFORMATION - JOHNSON & JOHNSON.
